Exploring the role of individual PI3K isoforms in different cells of the tumor microenvironment may contribute to the design of more effective combination therapies, because these inhibitors can be tolerated at doses leading to greater effective inhibition of their targets. Here, PIK3CA is linked to neoplasm.